RTK mutations and human syndromes - when good receptors turn bad

被引:128
作者
Robertson, SC [1 ]
Tynan, JA
Donoghue, DJ
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Ctr Genet Mol, La Jolla, CA 92093 USA
关键词
D O I
10.1016/S0168-9525(00)02021-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mutations in receptor tyrosine kinases (RTKs) have been linked to an increasing number of inherited human disease syndromes, including dwarfism, craniosynostosis, heritable cancer susceptibility, venous malformation and Piebaldism. Both gain-of-function mutations resulting in constitutive receptor activation, and loss-of-function mutations resulting in nan-functional or dominant negative receptors, have been observed. This review summarizes RTK families that are involved in inherited syndromes, describes the molecular consequences of the disease mutations, and predicts that many novel mutations remain to be identified.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 73 条
[31]  
JOHNSON DE, 1993, ADV CANCER RES, V60, P1
[32]  
Kahn CR, 1996, ANNU REV MED, V47, P509
[33]   NEUROTROPHIN SIGNAL-TRANSDUCTION BY THE TRK RECEPTOR [J].
KAPLAN, DR ;
STEPHENS, RM .
JOURNAL OF NEUROBIOLOGY, 1994, 25 (11) :1404-1417
[34]  
KIMAK M, 1999, AM J HUM GENET S, P65
[35]   Leprechaunism Donohue syndrome insulin receptor gene mutations: A syndrome delineation story from clinicopathological description to molecular understanding [J].
Kosztolanyi, G .
EUROPEAN JOURNAL OF PEDIATRICS, 1997, 156 (04) :253-255
[36]   Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis [J].
Longley, BJ ;
Metcalfe, DD ;
Tharp, M ;
Wang, XM ;
Tyrrell, L ;
Lu, SZ ;
Heitjan, D ;
Ma, YS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) :1609-1614
[37]   Congenital insensitivity to pain with anhidrosis:: Novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor [J].
Mardy, S ;
Miura, Y ;
Endo, F ;
Matsuda, I ;
Sztriha, L ;
Frossard, P ;
Moosa, A ;
Ismail, EAR ;
Macaya, A ;
Andria, G ;
Toscano, E ;
Gibson, W ;
Graham, GE ;
Indo, Y .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (06) :1570-1579
[38]   Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis [J].
McTigue, MA ;
Wickersham, JA ;
Pinko, C ;
Showalter, RE ;
Parast, CV ;
Tempczyk-Russell, A ;
Gehring, MR ;
Mroczkowski, B ;
Kan, CC ;
Villafranca, JE ;
Appelt, K .
STRUCTURE WITH FOLDING & DESIGN, 1999, 7 (03) :319-330
[39]   Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism [J].
Mohammadi, M ;
Schlessinger, J ;
Hubbard, SR .
CELL, 1996, 86 (04) :577-587
[40]   The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation [J].
Monsonego-Ornan, E ;
Adar, R ;
Feferman, T ;
Segev, O ;
Yayon, A .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (02) :516-522